Sanofi-Genzyme Ventures is a corporate venture capital fund dedicated to helping Genzyme Corporation achieve its strategic goals. Founded in 2001, the $100 million fund has a current portfolio of direct corporate investments and has taken LP position...Show all
Phone:
500 Kendall Street
Cambridge, 02142
Massachusetts, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2017-06-14 | Omada Health | Series D | $50M | Andreessen Horowitz, Cigna, Civilization Ventures , dRx Capital, GE Ventures, Humana Ventures, Kaiser Permanente Ventures, Norwest Venture Partners, Providence Ventures, and US Venture Partners |
| 2017-04-26 | Evidation Health | Series B - II | $10M | B Capital Group, and GE Ventures |
| 2017-04-25 | Science 37 | Series C | $29M | Amgen Ventures, dRx Capital, Glynn Capital Management, Google Ventures, Lux Capital, and Redmile Group |
| 2016-10-18 | Science 37 | Series B | $31M | dRx Capital, Lux Capital, and Redmile Group |
| 2016-02-10 | Yumanity Therapeutics | Series A | $45M | Alexandria Venture Investments, Biogen Idec New Ventures, Dolby Family Ventures, Fidelity Investments, and Redmile Group |
